Skip to content

Pilot Feasibility of Rice Bran Supplementation in Nicaraguan Children

Pilot Feasibility of Dietary Heat-Stabilized Rice Bran Supplementation for Diarrheal Disease Prevention in Nicaraguan Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02615886
Enrollment
47
Registered
2015-11-26
Start date
2014-11-30
Completion date
2015-10-31
Last updated
2017-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dietary Rice Bran Supplementation

Keywords

rice bran, infants, stool metabolome, stool microbiome, dietary intervention

Brief summary

The purpose is to assess feasibility of rice bran consumption in weaning children and collect pilot data on gut microbiome and metabolome modulation with rice bran intake for diarrheal prevention.

Detailed description

Rice bran is a globally accessible, underutilized food ingredient with an array of beneficial nutrients (e.g. phytochemicals and prebiotics) that promote health and potentially prevent diseases. The investigators will determine if dietary rice bran intake can modulate the infant gut microbiome and metabolome to promote gut immunity for the benefit of preventing diarrheal diseases that increase risk for malnutrition and stunting. The investigators hope to learn about the feasibility of dietary supplementation of heat-stabilized rice bran in weaning children living in regions with increased susceptibility to diarrhea and malnutrition, and whether or not rice bran consumption can modulate the stool microbiome and metabolome.

Interventions

Participants will be observed and not provided any dietary supplementation.

DIETARY_SUPPLEMENTRice bran

Dietary rice bran consumed daily and amounts increase throughout the 6 month intervention (6 months of age: 1 g/day rice bran, 7 months: 2 g/day rice bran, 8 months: 2 g/day, 9 months: 3g/day, 10 months: 4g/day, 11 months: 5g/day).

Sponsors

National Autonomous University of Nicaragua
CollaboratorOTHER
Virginia Polytechnic Institute and State University
CollaboratorOTHER
University of North Carolina, Chapel Hill
CollaboratorOTHER
Colorado State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
4 Months to 13 Months
Healthy volunteers
Yes

Inclusion criteria

* Children between the ages of 4 months and 6 months at beginning of recruitment * Have received the 3 doses of the rotavirus vaccination (RV5) * Families willing to feed their infant a daily dose of study-provided heat-stabilized rice bran for 6 months

Exclusion criteria

* Have had a diarrheal episode between 4 and 6 months of age * Have had a prior hospitalization * Have had an antibiotic or prophylactic treatment within 1 month prior to participation * Have an ongoing illness, a known immunocompromising condition, or use of medications

Design outcomes

Primary

MeasureTime frameDescription
Number of participants who are compliant to consuming rice bran daily and in amounts provided6 monthsRecord daily rice bran consumption and track compliance to diet intervention by regular visits from local study personnel.

Secondary

MeasureTime frameDescription
Number of participants with microbial modulations in stool as detected by microbiome sequencing.6 monthsMeasure the stool microbiome modulation with rice bran consumption for gut health and diarrhea prevention compared to no rice bran consumption.
Number of participants with metabolite modulations in stool as detected by Gas Chromatography-Mass Spectrometry (GC-MS) and Liquid Chromatography-Mass Spectrometry (LC-MS)6 monthsMeasure the stool metabolome modulation with rice bran consumption for gut health and diarrheal prevention compared to no rice bran consumption.

Countries

Nicaragua, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026